A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study-Reference-Cited by-同舟云学术

A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study

Published:2016-10-24 Issue: Volume:7 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Vitale Antonio,Insalaco Antonella,Sfriso Paolo,Lopalco Giuseppe,Emmi Giacomo,Cattalini Marco,Manna Raffaele,Cimaz Rolando,Priori Roberta,Talarico Rosaria,Gentileschi Stefano,de Marchi Ginevra,Frassi Micol,Gallizzi Romina,Soriano Alessandra,Alessio Maria,Cammelli Daniele,Maggio Maria C.,Marcolongo Renzo,La Torre Francesco,Fabiani Claudia,Colafrancesco Serena,Ricci Francesca,Galozzi Paola,Viapiana Ombretta,Verrecchia Elena,Pardeo Manuela,Cerrito Lucia,Cavallaro Elena,Olivieri Alma N.,Paolazzi Giuseppe,Vitiello Gianfranco,Maier Armin,Silvestri Elena,Stagnaro Chiara,Valesini Guido,Mosca Marta,de Vita Salvatore,Tincani Angela,Lapadula Giovanni,Frediani Bruno,De Benedetti Fabrizio,Iannone Florenzo,Punzi Leonardo,Salvarani Carlo,Galeazzi Mauro,Rigante Donato,Cantarini Luca

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference65 articles.

1. Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study];Abbate;Am. J. Cardiol.,2013

2. Efficacy and safety of the human anti-IL-1β monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, Phase, I. I., dose-finding study;Alten;BMC Musculoskelet. Disord.,2011

3. Canakinumab in recessive dystrophic epidermolysis bullosa: a novel unexpected weapon for non-healing wounds?;Annicchiarico;Clin. Exp. Rheumatol.,2016

4. Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes;Banerjee;Clin. Chim. Acta,2012

5. The use of IL-1 receptor antagonist (anakinra) in idiopathic recurrent pericarditis: a narrative review;Baskar;Cardiol. Res. Pract.,2016

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term safety profile and secondary effectiveness of canakinumab in pediatric rheumatic diseases: a single-center experience;Expert Opinion on Drug Safety;2024-08

2. Anakinra in the Management of Adult-Onset Still’s Disease: A Single-Center Experience;2024-03-21

3. Risk of Macrophage Activation Syndrome in Patients with Adult-Onset Still’s Disease Treated with IL-1 and IL-6 Inhibitors: A Meta-analysis and Single-Center Experience;Rheumatology and Therapy;2023-10-04

4. Efficacy and safety of anti-interleukin-1 treatment in familial Mediterranean fever patients: a systematic review and meta-analysis;Rheumatology;2023-09-28

5. Treatment with Biologic Drugs in Pediatric Behçet’s Disease: A Comprehensive Analysis of the Published Data;BioDrugs;2023-06-29